Le Lézard
Classified in: Transportation, Health, Science and technology, Business, Sports and recreation
Subject: LIC

USADA Adopts Ember LifeSciences Cold Chain Technology for Human Specimen Transport


LOS ANGELES, Feb. 27, 2024 /PRNewswire/ -- Ember LifeSciences, an innovator in the pharmaceutical cold chain industry and creator of the award-winning Ember Cube, and the U.S. Anti-Doping Agency (USADA) have announced a partnership to enhance the efficiency of the blood sample shipping processes for upcoming sporting events, including the highly anticipated 2024 U.S. Olympic Team Trials.

Ember LifeSciences' cold chain technology focuses on self-contained, self-monitoring shipping systems for items such as temperature-sensitive pharmaceuticals, vaccines, and lab specimens. The Ember Cube is the first product in the market that provides a fully integrated solution to common and costly challenges in cold chain shipping. Its patented innovative design addresses issues related to tracking and  temperature-sensitive deliveries, ensuring secure transport and preserved efficacy of medicines and specimens.

With its ability to bring improved visibility and accountability into the cold chain, the Ember Cube was used by USADA at several prestigious sporting events last year, including the Boston and New York Marathons with Olympic and Paralympic athletes and the Ironman World Championship in Kona. The Professional Fighters League also became the first MMA promotion to use the new technology for a fight in November.

Through these events, hundreds of blood samples from elite athletes were safely transported in Ember Cubes to drug testing labs across the United States. Leveraging Ember's cloud-based dashboard, USADA was able to monitor the real-time location, ambient temperature, and payload temperature of the Cubes during transit, ensuring that the blood samples maintained optimal temperatures and chain of custody was retained throughout the journey.

Beyond addressing shipment delays, the Ember Cube presented USADA with a cost-effective, integrated shipping solution given its reusability and advanced features including self-refrigeration capabilities to provide convenient storage of collected blood samples before and during transport. The Cube's integrated temperature monitoring also eliminated the need for a standalone temperature logger, enhancing the overall efficiency, simplicity, and reliability of the process.

"Preserving the integrity of athletes' blood samples is fundamental to ensuring a fair and level playing field," stated John Bobo, Chief Operating and Innovation Officer of USADA. "With the Ember Cube, we've deployed the most comprehensive and sustainable solution for ensuring the integrity and reliability of vital shipments from in-competition collections."

Building on the Ember Cube's successful performance at previous events, Ember LifeSciences has been selected by USADA as a trusted partner to transport samples at several 2024 U.S. Olympic Trials, including the recent marathon trials in Orlando, as well as the upcoming track and field trials in Eugene.

"We are honored to be chosen as a trusted partner by USADA and look forward to contributing to the integrity of sports through our strategic collaboration," said Clay Alexander, Founder and CEO of Ember LifeSciences. "Our partnership with USADA represents a powerful step forward in our mission to disrupt the cold chain for the healthcare industry."

About Ember LifeSciences

Ember LifeSciences initially launched as an offshoot of Ember Technologies, one of the fastest-growing companies in America known for its ground-breaking temperature control technology, global IP portfolio, and design-led brand. With the mission of improving the way people eat, drink, and live, Ember founder and serial inventor Clay Alexander set his sights on healthcare to revolutionize the cold chain to improve how we transport life-saving medicines and vaccines around the world. In 2022, the company developed the Ember Cube, the world's first self-refrigerated cloud-based shipping box. For more information, visit emberlifesciences.com.

About USADA (U.S. Anti-Doping Agency)

USADA conducts the year-round, independent anti-doping programs for all Olympic, Paralympic, and Professional Fighters League (PFL) athletes. USADA is an independent, nonprofit, non-governmental agency whose sole mission is to stand with athletes to champion their right to clean sport, inspire true and healthy sport, and promote the integrity of sport.

SOURCE Ember LifeSciences


These press releases may also interest you

at 06:00
Fennec Pharmaceuticals Inc. , a commercial stage specialty pharmaceutical company, today announced that Adrian Haigh has departed from his position as Fennec's Chief Operating Officer as of June 30, 2024. After nine years as an independent director,...

at 06:00
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") , a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced today that its board of directors...

at 06:00
BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced today that it will hold a mid-year corporate update to discuss recent positive developments in the NurOwn® program on...

at 05:26
Pope Francis hosted distinguished scientists and experts from various countries and disciplines at a private audience at the Apostolic Palace in Vatican City. The selected attendees were participants in the Three-day International Conference on...

at 05:05
LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, today announced the appointment of Staph Leavenworth Bakali as independent Chairman of its Board of Directors. Mr....

at 04:30
1 in 2 adults in the US have high blood pressure, and if you're over 55, the odds jump to 4 in 5. Given that heart attacks are the No.1 killer of men and women around the world, often precipitated by high blood...



News published on and distributed by: